SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Millogo GRC, Kologo JK, Kinda G, Yaméogo NV, Tougma JB, Kambiré Y, Thiam AT, Sanon B, Toguyeni JY, Samadoulougou A, Zabsonré P. Pan. Afr. Med. J. 2018; 29: 135.

Vernacular Title

Les accidents du traitement anticoagulant dans le Service de Cardiologie du Centre Hospitalier Universitaire Yalgado Ouedraogo de Ouagadougou (Burkina Faso).

Affiliation

UFR/SDS (Unité de Formation et de Recherche en Science de la Santé), Service de Cardiologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso.

Copyright

(Copyright © 2018, African Field Epidemiology Network)

DOI

10.11604/pamj.2018.29.135.10650

PMID

30050599

PMCID

PMC6057581

Abstract

This study aimed to evaluate the profile of patients hospitalized for anticoagulant-induced hemorrhage. We conducted a retrospective, descriptive study within the Department of Cardiology at the Yalgado Ouedraogo Teaching Hospital, in Ouagadougou, over a period of 2 years from 1 January 2007 to 31 December 2008. All hospitalized patients with anticoagulant-induced hemorrhage were included in the study. The average age of patients was 49,31 ± 17,68 years, the sex-ratio was 2,17. Myocardial infarction was the first indication for anticoagulant treatment, with a rate of 21.05%. Anti vitamin K (AVK) was associated with hemorrhage in 63,16% (n=12) of patients versus 36,84% (n=7) of patients treated with low molecular weight heparins (LMWH); 10 patients had major hemorrhage while nine patients had minor hemorrhage. The average duration of Anti vitamin K (AVK) treatment was 16 ± 58 weeks. Hemorrhage in the digestive tract was the most frequent symptom (31,58%) and, in 89,47% of patients, treatment was associated with platelet aggregation. Treatment of hemorrhagic accident was based on definitive cessation of anticoagulant therapy in 73,68% of patients. Four patients (21.05%) died. The inaccessibility to antidotes such as protamine sulphate and PPSD (Prothrombin, Proconvertine, Stuart factor, and anti-haemophilia B factor) constitutes a real obstacle to adequate treatment for complications; a better education of patients receiving these drugs would be the most important preventive measure, because more than 50% of these accidents are preventable.


Language: fr

Keywords

Anticoagulant; hemorrhage; venous thrombosis

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print